주식회사 셀레믹스

{
  "address": "서울특별시 금천구",
  "ceo_name": "김효기, 이용훈",
  "certificate": [
    {
      "cert_number": "20130102369",
      "changes": "",
      "disclosure_date": "2013-03-29",
      "first_cert_date": "2013-03-29",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2013-03-29 ~ 2015-03-28"
    },
    {
      "cert_number": "20150104962",
      "changes": "",
      "disclosure_date": "2015-05-28",
      "first_cert_date": "2013-03-29",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2015-05-28 ~ 2017-05-27"
    },
    {
      "cert_number": "20170108370",
      "changes": "",
      "disclosure_date": "2017-07-12",
      "first_cert_date": "2013-03-29",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2017-05-28 ~ 2019-05-27"
    },
    {
      "cert_number": "20190107180",
      "changes": "",
      "disclosure_date": "2019-06-26",
      "first_cert_date": "2013-03-29",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2019-05-28 ~ 2021-05-27"
    },
    {
      "cert_number": "20210707030231",
      "changes": "",
      "disclosure_date": "2021-07-07",
      "first_cert_date": "2013-03-29",
      "no": "5",
      "type": "혁신성장유형",
      "valid_period": "2021-05-28 ~ 2024-05-27"
    },
    {
      "cert_number": "20240703030068",
      "changes": "",
      "disclosure_date": "2024-07-03",
      "first_cert_date": "2013-03-29",
      "no": "6",
      "type": "혁신성장유형",
      "valid_period": "2024-05-28 ~ 2027-05-27"
    }
  ],
  "company_name": "주식회사 셀레믹스",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 4082074000,
      "cost_of_sales": 6305447000,
      "current_assets": 15612826000,
      "current_liabilities": 2644840000,
      "gross_profit": 2423493000,
      "net_income": -4796931000,
      "net_income_bs": -4796932000,
      "non_current_assets": 6598603000,
      "non_current_liabilities": 977353000,
      "non_operating_expenses": 78383000,
      "non_operating_income": 1015354000,
      "operating_profit": -5733902000,
      "revenue": 8728940000,
      "sga_expenses": 8157395000,
      "total_assets": 22211429000,
      "total_equity": 18589235000,
      "total_liabilities": 3622193000
    },
    "2023": {
      "capital_stock": 4082074000,
      "cost_of_sales": 5055097000,
      "current_assets": 12685916000,
      "current_liabilities": 1649083000,
      "gross_profit": 1522481000,
      "net_income": -3874540000,
      "net_income_bs": -3874540000,
      "non_current_assets": 5433907000,
      "non_current_liabilities": 587139000,
      "non_operating_expenses": 80055000,
      "non_operating_income": 1974786000,
      "operating_profit": -5769271000,
      "revenue": 6577578000,
      "sga_expenses": 7291752000,
      "total_assets": 18119822000,
      "total_equity": 15883600000,
      "total_liabilities": 2236222000
    }
  },
  "industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
  "investment": [],
  "main_products": "유전체 진단용 시약 및 키트 제조",
  "phone": "02-6746-****",
  "years": [
    2023,
    2022
  ]
}